Clinical Trial Update: Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating rosiglitazone maleate for treating oral leukoplakia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Leukoplakia

Drugs mentioned

• Rosiglitazone Maleate (rosiglitazone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Oral Leukoplakia | Phase 2 | Status: COMPLETED